What it sells
AI-powered electronic nose (e-nose) hardware and models that detect disease-related volatile organic compounds, starting with urine samples.
Business model breakdown
Trigger: what makes them buy now?
Nearly half of cancers are found too late, after symptoms appear.
Workflow: what inputs become what output?
Olfactory chip detects dozens of VOCs in parallel in urine, sweat and other fluids; in-house AI model trained on smell patterns screens and monitors biomarkers non-invasively.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-09-09 | Pre-seed | £700K | Zinc and SFC Capital (co-leads), Innovate UK support | uktechnews.info |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.